menu

Atopic Dermatitis: The Clinical Art of Diagnosis with Attention to Comorbidities

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Atopic Dermatitis: The Clinical Art of Diagnosis with Attention to Comorbidities

close
0.50 credits
30 minutes
Atopic Dermatitis: The Clinical Art of Diagnosis with Attention to Comorbidities
RestartResume
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
Details
Presenters
Related
Comments
  • Overview

    There are many challenges clinicians face when diagnosing atopic dermatitis, but reaching an accurate diagnosis is essential in not only beginning treatment sooner, but also in managing its comorbidities. Joining Dr. Jennifer Caudle are allergist Dr. Anna Fishbein and dermatologist Dr. Lindsay Strowd, who use a patient case to demonstrate their approach to diagnosing atopic dermatitis.

  • Learning Objectives

    • Differentiate AD from other conditions and among various age groups in a timely manner
    • Address comorbidities when planning AD care

    ·       

  • Target Audience

    The primary audience who will use and benefit from this educational initiative includes dermatologists, allergists, nurse practitioners, physician assistants, and nurses who manage patients of all ages with Atopic Dermatitis.

  • Disclosure of Conflicts of Interest

    Anna Fishbein, MD, has nothing to disclose.
    Lindsay C. Strowd, MD, FAAD, has done contract research for Pfizer, Inc.

  • Accreditation and Credit Designation Statements

    The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The France Foundation designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory,  Atopic Dermatitis: The Clinical Art of Diagnosis with Attention to Comorbidities has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

    MOC Part II CME
    Allergy and Immunology

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals. 

  • Terms of Use

    TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

    METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

    Technical Requirements: http://www.francefoundation.com/general-requirements.html

    1. There are no fees for participating in and receiving credit for this activity.
    2. Review the activity objectives and CME/CE information.
    3. Complete the CME/CE activity
    4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
    5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice, the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his/her views on future educational needs.
    6. Credit documentation/reporting:

    If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download.

    If you are claiming ABAI MOC Part II points, please retain your certificate and submit as proof to the ABAI board as evidence that you completed the activity.

  • Disclaimer

    The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    There are many challenges clinicians face when diagnosing atopic dermatitis, but reaching an accurate diagnosis is essential in not only beginning treatment sooner, but also in managing its comorbidities. Joining Dr. Jennifer Caudle are allergist Dr. Anna Fishbein and dermatologist Dr. Lindsay Strowd, who use a patient case to demonstrate their approach to diagnosing atopic dermatitis.

  • Learning Objectives

    • Differentiate AD from other conditions and among various age groups in a timely manner
    • Address comorbidities when planning AD care

    ·       

  • Target Audience

    The primary audience who will use and benefit from this educational initiative includes dermatologists, allergists, nurse practitioners, physician assistants, and nurses who manage patients of all ages with Atopic Dermatitis.

  • Disclosure of Conflicts of Interest

    Anna Fishbein, MD, has nothing to disclose.
    Lindsay C. Strowd, MD, FAAD, has done contract research for Pfizer, Inc.

  • Accreditation and Credit Designation Statements

    The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The France Foundation designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory,  Atopic Dermatitis: The Clinical Art of Diagnosis with Attention to Comorbidities has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

    MOC Part II CME
    Allergy and Immunology

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals. 

  • Terms of Use

    TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

    METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

    Technical Requirements: http://www.francefoundation.com/general-requirements.html

    1. There are no fees for participating in and receiving credit for this activity.
    2. Review the activity objectives and CME/CE information.
    3. Complete the CME/CE activity
    4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
    5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice, the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his/her views on future educational needs.
    6. Credit documentation/reporting:

    If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download.

    If you are claiming ABAI MOC Part II points, please retain your certificate and submit as proof to the ABAI board as evidence that you completed the activity.

  • Disclaimer

    The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 2/24/20